Murtaza Adam, MD
Retina Specialist · Parker, CONPI 1093004806
Payments from drug & device makers
Across 1,005 payments — averaging $2045.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$1.3M
- Regeneron$201K
- Regeneron Healthcare Solutions, Inc.$134K
- Astellas Pharma US Inc$133K
- Apellis Pharmaceuticals, Inc.$105K
- Genentech USA, Inc.$87K
- plus $115K from 20 others
Across 3 payments — averaging $2453.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$7K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 167 | $1,280,594 |
| Regeneron | 333 | $201,489 |
| Regeneron Healthcare Solutions, Inc. | 117 | $133,829 |
| Astellas Pharma US Inc | 98 | $133,204 |
| Apellis Pharmaceuticals, Inc. | 72 | $104,803 |
| Genentech USA, Inc. | 93 | $87,052 |
| Hoffmann-la Roche Limited | 14 | $38,734 |
| AbbVie(2 entities) | 36 | $32,387 |
| Novartis | 35 | $26,259 |
| Dutch Ophthalmic, USA | 7 | $4,343 |
| Neurotech Pharmaceuticals, Inc. | 1 | $3,155 |
| Astellas Pharma Global Development | 2 | $3,132 |
| F. Hoffmann-la Roche AG | 3 | $3,100 |
| Eyepoint US, Inc. | 4 | $1,672 |
| Alcon | 4 | $896 |
| Alimera Sciences, Inc. | 4 | $551 |
| Carl Zeiss Meditec USA, Inc. | 1 | $153 |
| Topcon Healthcare, Inc. | 1 | $104 |
| Biogen | 4 | $75 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
| Ocular Therapeutix, Inc. | 1 | $50 |
| Harrow Eye, LLC | 2 | $39 |
| Coherus Oncology, Inc. | 2 | $35 |
| Boston Scientific | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Kala Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$2,055,784 in reported general payments places this provider in the 90th percentile of 51 retina specialist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Parker
- Sara HaugDurango$9.5M
- James LuuColorado Springs$2.9M
- Mimi LiuEnglewood$2.2M
- Ramin SarrafizadehColorado Springs$1.7M
- Brian JoondephDenver$1.6M
- Mark ChittumColorado Springs$1.2M
- Stanford TaylorColorado Springs$879K
- Nancy ChristmasDenver$775K
- Scott OliverAurora$590K
- Alan KimuraDenver$546K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.